What we’ve learned from the introduction of high-cost hepatitis C drugs should be used for effective stakeholder alignment and the rollout of future curative therapies: The development of Sovaldi, Harvoni and other leading-edge therapies for hepatitis C was driven in large part by payer and patient demands for drugs with proven cure rates. Manufacturers responded […]
Curant Health President and CEO, Patrick Dunham, and Director of Clinical Services, Vickie Andros, discuss our C the Cure program hepatitis c cure rate for co-infected HIV and hepatitis C patients. Access assistance and MTM protocols key to successfully curing hepatitis C in co-infected patients. For a cohort of hepatitis C and HIV co-infected patients, Curant Health reports […]
Access assistance and MTM protocols key to successfully curing hepatitis C in co-infected patients. May 2, 2016 - Atlanta, Georgia - For a cohort of hepatitis C and HIV co-infected patients, Curant Health reports that its C The Cure program produces sustained virological response (SVR12) in 89.7% of program patients at 12 weeks post treatment. […]
April 29, 2016 - The University of South Florida (USF) Alumni Association honored the 2016 USF Fast 56 – the fastest growing USF alumni owned or led businesses in the world, in the Marshall Student Center Ballroom and Oval Theater at USF Tampa. Curant Health, led by Patrick Dunham, is passionate about improving the lives […]
When it comes to value-based care, the technology surrounding healthcare information is not at 100%. There is opportunity for improvement in the following ways: More advanced patient facing Health Information Technology (HIT) Advanced HIT tools are now able to pinpoint the gaps in patient information narrowed down to specific moments in care. Not only can […]
April 23, 2016 - Curant Health President and CEO, Patrick Dunham, featured in Managed Healthcare Executive - As health information technology (HIT) proliferates at breakneck speed, it still falls short in several areas critical to the realization and advancement of value-based care. Here are the top opportunities for technology to provide meaningful improvements in patient […]
April 22, 2016 - Atlanta, Georgia - The Atlanta Business Chronicle recently named Curant Health as one of Atlanta’s top 100, fastest-growing, privately owned companies, ranking in at #23. Each year the publication recognizes organizations for their “unconventional methods and top speed growth,” demonstrating stability, adaptability and sustained, explosive successes year-over-year. This is the fourth […]
Tracey Childs, our newest Curant Cares award winner! Congratulations to Tracey Childs, Office Administrator in our Georgia location, for being nominated as our third recipient of the Curant Cares Award! Tracey takes her responsibilities toward our patients and our Curant team members to the next level of helpfulness, assistance and value. Tracey goes above and […]
Prior to Armada 2015, my colleagues and I spoke about the dire need for greater alignment among all stakeholders in the pharmaceutical industry. While there have been some advancements in this regard over the past 12 months, they are painfully slow and need acceleration. Within their individual silos, manufacturers and payers continue delivering for their […]
April 12, 2016 - Curant Health COO, Marc O'Connor, featured in Managed Healthcare Executive - #4. Don’t overlook the capability specialty pharmacy partners. “Engagement with specialty pharmacy partners with proven MTM programs has shown to add measurable value, improve medication adherence, patient outcomes and reduce overall healthcare costs,” according to Marc O’Connor, COO with medication management […]
